Achilles Therapeutics Plc buy BiotechBee
Start price
17.03.24
/
60%
€0.98
Target price
31.12.25
€2.50
Performance (%)
-29.23%
Price
26.04.24
€0.72
Summary
This prediction is currently active. The price of Achilles Therapeutics Plc has decreased since the start of the prediction. Compared to the start price this results in a performance of -29.23%. This prediction currently runs until 31.12.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Achilles Therapeutics Plc | -2.703% | -2.703% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
According to BiotechBee what are the pros and cons of Achilles Therapeutics Plc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Achilles Therapeutics Plc diskutieren
Stopped prediction by BiotechBee for Achilles Therapeutics Plc
Achilles Therapeutics Plc
Start price
Target price
Perf. (%)
€0.97
18.02.24
18.02.24
€2.00
31.01.26
31.01.26
0.52%
17.03.24
17.03.24
Could be very worthwhile Investment >20% year
